JERUSALEM (Reuters) – Israel’s IceCure Medical said on Sunday it received U.S. regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%. IceCure’s treatment ... More »
(Reuters Health) – The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money. Anticancer medications account for the lion’s share of glob... More »
(Reuters Health) – Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs, a U.S. study suggests. Researchers examined data on payments drug companies made to doctors in 201... More »
(Reuters Health) – Most Americans aren’t aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, a U.S. study suggests. In a nationally representative survey of 420 adults, just 16 percent said they knew... More »
Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. More »
By Andrew M. Seaman(Reuters Health) – People who want access to the best cancer treatment centers in the U.S. may want to avoid health insurance pla More »
By Carolyn Crist(Reuters Health) – Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a phar More »
By Lisa Rapaport(Reuters Health) – Comfort care for advanced cancer patients is associated with fewer repeat hospitalizations and more hospice referr More »
By Madeline Kennedy(Reuters Health) – As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with pa More »
By Andrew M. Seaman(Reuters Health) – In general, childhood cancer survivors are just as satisfied with their sex lives as people who didn’t have ca More »
By Andrew M. Seaman(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits va More »
By Kathryn Doyle(Reuters Health) – For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not ju More »
(Reuters Health) – U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a rece... More »
